A sobering look at gunfire statistics in St. Louis

A sobering look at gunfire statistics in St. Louis

During a five-year period ending in 2013, nearly 400 children ages 16 or under were taken to one of two hospital emergency rooms in St. Louis for gun-related injuries, according to a study led by Martin S. Keller, MD, at Washington University School of Medicine in St. Louis. Of those children, 20 later died. Analyzing such cases can help identify risk factors and stem gun-related injuries, researchers believe.
Study uncovers hard-to-detect cancer mutations ​

Study uncovers hard-to-detect cancer mutations ​

New research, led by Li Ding, PhD, shows that current genome analysis approaches systematically miss detecting a certain type of complex mutation in cancer patients’ tumors. A significant percentage of these complex mutations are found in well-known cancer genes that could be targeted by existing drugs, potentially expanding the number of cancer patients who may benefit.
New center focuses on regenerative medicine

New center focuses on regenerative medicine

A new center has been formed at Washington University School of Medicine in St. Louis to facilitate research that explores the regenerative properties of cells and tissues. The Center of Regenerative Medicine is headquarted in the recently opened 4515 McKinley Research Building, along with several other School of Medicine centers and divisions.
Goldberg named Kipnis Distinguished Professor

Goldberg named Kipnis Distinguished Professor

Daniel E. Goldberg, MD, PhD, a renowned researcher in molecular parasitology, has been named the inaugural David M. and Paula L. Kipnis Distinguished Professor. Goldberg, who earned his medical degree and a doctorate in molecular biology from Washington University, is a longtime professor of medicine and of molecular microbiology at the School of Medicine.
Research points to development of single vaccine for Chikungunya, related viruses​

Research points to development of single vaccine for Chikungunya, related viruses​

Researchers at Washington University School of Medicine​ in St. Louis have identified “broadly neutralizing” antibodies that protect against infection by multiple, distantly related alphaviruses – including Chikungunya virus – that cause fever and debilitating joint pain. The discovery, in mice, lays the groundwork for a single vaccine or antibody-based treatment against many different alphaviruses.
​Scientists receive $13.7 million to develop new multiple myeloma treatments​​​​​​​

​Scientists receive $13.7 million to develop new multiple myeloma treatments​​​​​​​

Researchers at the School of Medicine have been awarded $13.7 million from the National Cancer Institute (NCI) to create new therapies for multiple myeloma, a cancer of the immune system.​ Led by Samuel Achilefu, PhD, (pictured) and Gregory Lanza, MD, PhD, at the newly created Center for Multiple Myeloma Nanotherapy, scientists will work to develop nanomaterials and drugs to treat the disease.
Older Stories